Status:
COMPLETED
Telerehabilitation Alzheimer's Disease Usability (TADU)
Lead Sponsor:
Bright Cloud International Corp
Collaborating Sponsors:
National Institute on Aging (NIA)
Rutgers, The State University of New Jersey
Conditions:
Alzheimer Disease
Healthy Aging
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
Usability evaluation of BrightGo cognitive telerehabilitation system. An experimental system was developed to enhance standard of care (medication effect) for Early Alzheimer's Disease populations. Th...
Detailed Description
Study will start with 2 elderly healthy volunteers (one male and one female) with preference to those with no computer game experience. The healthy volunteers will each perform usability sessions (2 t...
Eligibility Criteria
Inclusion
- Inclusion Criteria for healthy volunteers:
- Good or corrected hearing;
- Good or corrected vision;
- No motor or cognitive impairments;
- English speaker;
- Willing to travel to usability site (NJ Bioscience Center)
- Inclusion Criteria for individuals with early Alzheimer's Disease:
- Age 65 to 85;
- Diagnosis of early Alzheimer's (Montreal Cognitive Assessment \[MoCA\] score of 19-25) \[Nasreddine et al 2005\].
- English speakers;
- Ability to actively move UE and to flex/extend fingers;
- Stable on Aricept 10 mg daily intake, or Exelon 9.5 mg patch medication
- Able to consent;
- Good or corrected hearing;
- Good or corrected vision;
- Good upper extremity motor function, close to full range of movement of arms and fingers;
- Willing to travel to usability site (NJ Bioscience Center)
- Exclusion Criteria:
- Those younger than 65;
- Severe visual impairments or legally blind;
- Severe hearing loss or deafness;
- Uncontrolled hypertension (\>190/100 mmHg);
- Severe cognitive delay (MoCA \<19);
- non-English speakers;
- Those unable to provide consent;
- Unable to move arms and fingers, or with severe arthritis;
- Severe propensity to simulation sickness;
Exclusion
Key Trial Info
Start Date :
July 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 7 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04731311
Start Date
July 29 2021
End Date
September 7 2021
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bright Cloud Int'l Corp
North Brunswick, New Jersey, United States, 08902